SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-004639
Filing Date
2020-02-13
Accepted
2020-02-13 17:06:53
Documents
70
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q urov-10q_20191231.htm 10-Q 2552637
2 EX-3.3 urov-ex33_33.htm EX-3.3 678807
3 EX-31.1 urov-ex311_6.htm EX-31.1 17904
4 EX-31.2 urov-ex312_7.htm EX-31.2 17914
5 EX-32.1 urov-ex321_8.htm EX-32.1 9679
6 EX-32.2 urov-ex322_9.htm EX-32.2 9668
7 GRAPHIC ggj02emzqqvc000004.jpg GRAPHIC 12824
8 GRAPHIC ggj02emzqqvc000001.jpg GRAPHIC 23519
9 GRAPHIC ggj02emzqqvc000003.jpg GRAPHIC 11999
10 GRAPHIC ggj02emzqqvc000002.jpg GRAPHIC 21687
  Complete submission text file 0001564590-20-004639.txt   7791638

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE DOCUMENT urov-20191231.xml EX-101.INS 1122168
12 XBRL TAXONOMY EXTENSION SCHEMA urov-20191231.xsd EX-101.SCH 52773
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE urov-20191231_cal.xml EX-101.CAL 52854
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE urov-20191231_def.xml EX-101.DEF 205668
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE urov-20191231_lab.xml EX-101.LAB 435770
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urov-20191231_pre.xml EX-101.PRE 350583
Mailing Address 5281 CALIFORNIA AVENUE SUITE 100 IRVINE CA 92617
Business Address 5281 CALIFORNIA AVENUE SUITE 100 IRVINE CA 92617 949-226-6029
Urovant Sciences Ltd. (Filer) CIK: 0001740547 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-38667 | Film No.: 20611871
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences